UBS Downgrades Republic Services to Neutral

UBS analyst Jon Windham downgrades Republic Services (NYSE:RSG) from Buy to Neutral.

UBS analyst Jon Windham downgrades Republic Services (NYSE:RSG) from Buy to Neutral.

Total
0
Shares
Related Posts
Read More

Cidara Therapeutics To Present Ongoing Development Of Drug-Fc Conjugates Including CD73-Targeting DFC From Its Cloudbreak Platform At Adenosine-Pathway Targeted Cancer Immunotherapy Summit Held June 20-22, 2023

Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious diseases, today announced that the company

CDTX